Barclays PLC Boosts Stock Position in The Ensign Group, Inc. $ENSG

Barclays PLC raised its holdings in The Ensign Group, Inc. (NASDAQ:ENSG) by 6.6% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 136,240 shares of the company’s stock after acquiring an additional 8,445 shares during the quarter. Barclays PLC owned approximately 0.24% of The Ensign Group worth $23,538,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of The Ensign Group by 9.9% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 161,946 shares of the company’s stock worth $20,956,000 after purchasing an additional 14,590 shares during the last quarter. Geneos Wealth Management Inc. lifted its holdings in The Ensign Group by 150.3% during the 1st quarter. Geneos Wealth Management Inc. now owns 383 shares of the company’s stock valued at $50,000 after buying an additional 230 shares in the last quarter. Wedbush Securities Inc. bought a new stake in The Ensign Group during the 2nd quarter valued at about $202,000. Penserra Capital Management LLC purchased a new stake in The Ensign Group in the 2nd quarter valued at about $231,000. Finally, Connor Clark & Lunn Investment Management Ltd. grew its stake in The Ensign Group by 339.1% in the 2nd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 8,856 shares of the company’s stock worth $1,366,000 after acquiring an additional 6,839 shares in the last quarter. Hedge funds and other institutional investors own 96.12% of the company’s stock.

The Ensign Group Stock Performance

Shares of ENSG opened at $210.43 on Thursday. The company has a current ratio of 1.42, a quick ratio of 1.42 and a debt-to-equity ratio of 0.06. The firm has a market cap of $12.19 billion, a PE ratio of 36.03, a P/E/G ratio of 2.06 and a beta of 0.83. The Ensign Group, Inc. has a 12 month low of $118.73 and a 12 month high of $218.00. The stock has a fifty day moving average price of $192.80 and a 200-day moving average price of $182.43.

The Ensign Group (NASDAQ:ENSG) last announced its earnings results on Wednesday, February 4th. The company reported $1.82 earnings per share for the quarter, topping the consensus estimate of $1.75 by $0.07. The Ensign Group had a return on equity of 16.76% and a net margin of 6.80%.The firm had revenue of $1.36 billion for the quarter, compared to the consensus estimate of $1.37 billion. During the same period in the previous year, the business earned $1.49 EPS. The firm’s revenue for the quarter was up 20.2% on a year-over-year basis. The Ensign Group has set its FY 2026 guidance at 7.410-7.610 EPS. Equities research analysts predict that The Ensign Group, Inc. will post 5.59 earnings per share for the current fiscal year.

The Ensign Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Saturday, January 31st. Stockholders of record on Wednesday, December 31st were paid a dividend of $0.065 per share. The ex-dividend date was Wednesday, December 31st. This is a positive change from The Ensign Group’s previous quarterly dividend of $0.06. This represents a $0.26 dividend on an annualized basis and a dividend yield of 0.1%. The Ensign Group’s payout ratio is presently 4.45%.

Insider Activity

In other The Ensign Group news, CFO Suzanne D. Snapper sold 8,258 shares of the company’s stock in a transaction that occurred on Thursday, February 5th. The shares were sold at an average price of $194.48, for a total transaction of $1,606,015.84. Following the transaction, the chief financial officer owned 277,462 shares in the company, valued at approximately $53,960,809.76. This represents a 2.89% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, VP Beverly B. Wittekind sold 8,400 shares of the firm’s stock in a transaction on Friday, December 12th. The stock was sold at an average price of $175.48, for a total transaction of $1,474,032.00. Following the completion of the transaction, the vice president directly owned 32,779 shares of the company’s stock, valued at approximately $5,752,058.92. This represents a 20.40% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 27,473 shares of company stock valued at $5,167,422. 3.90% of the stock is owned by company insiders.

Analyst Ratings Changes

ENSG has been the topic of several research analyst reports. Wall Street Zen raised The Ensign Group from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Truist Financial set a $215.00 target price on The Ensign Group and gave the company a “hold” rating in a research report on Friday, February 6th. Royal Bank Of Canada reissued an “outperform” rating and set a $222.00 price target (up from $206.00) on shares of The Ensign Group in a research report on Monday, February 9th. Weiss Ratings restated a “buy (b)” rating on shares of The Ensign Group in a research note on Thursday, January 22nd. Finally, UBS Group set a $230.00 price objective on The Ensign Group and gave the company a “buy” rating in a report on Friday, February 6th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Buy” and an average target price of $204.60.

The Ensign Group Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.